GO
Loading...

Investors Crushin' on Rare Diseases

Tuesday, 14 Feb 2012 | 2:15 PM ET

CNBC's Seema Moody reports on heightened interest in treating rare diseases as more patents expire. BioMarin Pharmaceutical is one of the leaders in this space, and its CEO Jean-Jacques Biename, weighs in.